RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, 12-13 Maggio 2016.

Slides:



Advertisements
Similar presentations
Modifiers of cell survival: Linear Energy Transfer Lecture Ahmed Group
Advertisements

From Radiobiology to Radiation Therapy: Action of Heavy Charged Particles in Biological Material 1 Institute of Physics, Jagellonian University, Krakow,
Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
Heavy charged particles for cancer radiation therapy (HST.187) Introduction (Bragg peak, LET, OER, RBE) I.Physical rationale II.Biological rationale III.Clinical.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
TRAINING COURSE ON RADIATION DOSIMETRY: Radiobiology Basics – RBE, OER, LET Anthony WAKER University of Ontario Institute of Technology Thu. 22/11/2012,
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
Radiation therapy is based on the exposure of malign tumor cells to significant but well localized doses of radiation to destroy the tumor cells. The.
Time, Dose, and Fractionation
Heavy Ion Tumor Therapy
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Predictive models validated by clinical data: new strategies for fractionation Dr. M. Benassi Dr. S. Marzi.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
First Year Workshop 2014 Miriam Lafiandra
Ischemic Heart Disease Following Left Breast Irradiation with Active Breathing Control (ABC): 10 year Outcomes and Risk Modeling Abstract 1027 Presenter:
P. Scampoli - 24th ICNTS Bologna, September 4,
The Increased Biological Effectiveness of Heavy Charged Particle Radiation: From Cell Culture Experiments to Biophysical Modelling Michael Scholz GSI Darmstadt.
BIANCA *, a model of radiation-induced cell death: biophysical mechanisms and possible applications for hadron therapy *BIophysical ANalysis of Cell death.
May 31, th PTCOG in Catania, Italy1 Treatment Planning for Broad-Beam 3D Irradiation Heavy-Ion Radiotherapy N. Kanematsu, M. Endo, and T. Kanai,
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
Mathematical Modelling within Radiotherapy: The 5 R’s of Radiotherapy and the LQ model. Helen McAneney 1 and SFC O’Rourke 1,2 1 School Mathematics and.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Brachytherapy and GYN malignancy
RADIOBIOLOGY. Principles of Radiobiology based on n Random nature of radiation interactions n how radiation interacts at cellular level n factors that.
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Experimental Cave at Trento CPT: status update Francesco Tommasino RDH/IRPT Meeting – Roma, 1 Feb 2016.
Clinical Application of Carbon Therapy
The use of Radiotherapy in Cancer.. What is radiotherapy? The treatment of cancer with ionising radiation is called Radiotherapy or Radiation Oncology.
UNIVERSAL SURVIVAL CURVE AND SINGLE FRACTION EQUIVALENT DOSE: USEFUL TOOLS IN UNDERSTANDING POTENCY OF ABLATIVE RADIOTHERAPY CLINT PARK, M.D. M.S., LECH.
MCS overview in radiation therapy
WP2 Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and.
Fuchs H – Particle beam therapy be using helium ions? – Birmingham 2016 Can particle beam therapy be improved using helium ions? 1,2 Fuchs H, 1,2 Knäusl.
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Rad T 110 Sherer Biologic Effects of Radiation Exposure.
Beam specific PTV incorporating 4DCT for PBS proton therapy of thoracic tumors Minglei Kang, PhD Authors: Liyong Lin1*, Minglei Kang1*, Sheng Huang1,
Particle Therapy at GSI
Linear Energy Transfer and Relative Biological Effectiveness
Proposal for a new INFN experiment
Radiological Protection in Ion Beam Radiotherapy
From Microdosimetry to Nanodosimetry
The Law of Bergonie & Tribondeau
UNILAC requirements for BIOPHYSICS research
INTERACTION OF PARTICLES WITH MATTER
L M Smyth, P A Rogers, J C Crosbie & J F Donoghue
International Workshop on radiosensitization
DNA repair kinetics: the effect of dose and radiation quality
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
Y. Yan1, V. Adhikarla1, M. W. Kissick1,2, D. Campos1, D. H. Zhao1, S
RTMR 284 Chapter 30 : Fundamental Principles of Radiobiology
أجهزة العلاج الإشعاعي Clinical Radiation Generator
M. D. Anderson Cancer Center Houston, TX
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
Figure 6 Double opposed-field irradiation of an idealized geometry
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
Figure 5 The biological effects of charged particles
Figure 2 Nonmalignant tissue can be spared from radiation
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
Figure 3 Clinical trial design in charged-particle therapy (CPT)
Overcoming resistance of cancer stem cells
Neoadjuvant Adjuvant Curative Palliative
Potential clinical impact of laser-accelerated beams in cancer therapy
Figure 1 Overview of the imaging biomarker roadmap
Nanoparticles for enhancing the effectiveness of proton therapy
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Principles of Radiation Therapy
Presentation transcript:

RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016

Basic concepts of radiation biophysics Workshop: la radiobiologia in INFN – Trento, Maggio 2016

Basic concepts of radiation biophysics  The DNA Double Strand Break (DSB) is considered the type of lesion most directly related to cell killing  Different radiation qualities produce the same spectrum of DNA lesions  BUT the distribution of lesions inside the target can be very different Workshop: la radiobiologia in INFN – Trento, Maggio 2016 Scholz 2006 Adv Pol Sci

Basic concepts of radiation biophysics  The DNA Double Strand Break (DSB) is considered the type of lesion most directly related to cell killing  Different radiation qualities produce the same spectrum of DNA lesions  BUT the distribution of lesions inside the target can be very different 12 C High LET 1 MeV/u, ≈ 690 keV/  m 12 C Low LET 200 MeV/u, ≈ 16 keV/  m Photons x-rays Random DSB distribution Workshop: la radiobiologia in INFN – Trento, Maggio 2016 Scholz 2006 Adv Pol Sci

High tumor dose, normal tissue sparing Effective for radioresistant tumors Effective against hypoxic tumor cells Increased lethality in the target because cells in radioresistant (S) phase are sensitized Fractionation spares normal tissue more than tumor Reduced angiogenesis and metastatization Potential advantages Energy LET Dose RBE OER Cell-cycle dependence Fractionation dependence Angiogenesis Cell migration Tumor Normal tissue high low low high  1 > 1  3 < 3 high low Increased Decreased Relative dose Depth (mm) Durante & Loeffler, Nature Rev Clin Oncol 2010 Charged particle therapy: improved physics and enhanced biological effectiveness

Relative Biological Effectiveness (RBE): RBE depends on: -Physical parameters (dose, LET, fractionation). -Biological parameters (cell cycle, oxygenation, end-point). Workshop: la radiobiologia in INFN – Trento, Maggio 2016

RBE: what’s on the market Data from PIDE (Friedrich 2014 J Rad Res) -Most data for high  ratio -Few data for 1 H and 4 He at high E -Very poor description for 16 O

RBE for protons Workshop: la radiobiologia in INFN – Trento, Maggio 2016

RBE=1.1 for protons in radiation therapy (ICRU recommendations) Paganetti 2002 PMB Workshop: la radiobiologia in INFN – Trento, Maggio 2016

RBE≠1.1 Classical Radiobiology New Paradigm for Proton Radiobiology H He Belli 2000 Int J Rad Biol Girdhani 2013 Radiat Res Currently trend toward variable RBE: -Primary beam: Range uncertainty, LET distribution -Secondary particles: Target fragments in entrance channel Workshop: la radiobiologia in INFN – Trento, Maggio 2016

…are deviations from 1.1 of clinical relevance? Wedenberg 2014 Med Phys -Potential improvements offered by biological optimization -Possible bias when neglecting variable RBE -Sensitivity to RBE model -Only 3 patients considered! Dose (Gy)Dose (Gy-RBE) LET (keV/  m) Workshop: la radiobiologia in INFN – Trento, Maggio 2016

Biological Range uncertainty (additional to physical range uncertainty!) Grün 2013 Med Phys Distal SOBP: -Parallel decrease of dose and increase in LET -RBE is highly uncertain -RBE can be >>1 in OAR!! -Better characterization -> more accurate treatments Range defined as distal D80 Cuaron 2016 IJROBP Workshop: la radiobiologia in INFN – Trento, Maggio 2016 DSB induction and repair

About 200,000 new cases per year in U.S Most patients survive (> 2 millions survivors) Majority receives radiation “Horror” stories from side effects of radiation leads many women to choose mastectomy over X-rays Cardio-pulmonary toxicity is an issue Protons for breast cancer Department of Physics - University of Trento Darby et al 2012 New Eng J Med Ares et al Int J Rad Oncol Biol Phys

Physical Dose Clinical Outcome ? NTCP models Workshop: la radiobiologia in INFN – Trento, Maggio 2016 Protons will lead to improved clinical outcomes (less serious toxicity) if: 1.Normal tissue sparing can be obtained (  dose)  dose will result in lower clinically significant complication risks (  NTCP) Radiotherapy and Oncology 2013Int J Rad Oncol Biol Phys 2016

Target fragmentation in proton therapy About 10% of biological effect in the entrance channel due to secondary fragments Largest contributions of recoil fragments expected from He, C, Be, O, N Heavy fragments have low residual energies and release low doses -> high RBE!! Workshop: la radiobiologia in INFN – Trento, Maggio 2016 Tommasino & Durante 2015 Cancers

Impact of target fragmentation in clinical practice -Currently the contribution of target fragments is implicit (RBE=1.1) -Improved description would be needed for:  Better definition of peak-to-entrance ratio  Side effects in the entrance channel (NTCP) and dose to target (TCP)  Prediction of secondary cancer risks  Implications for space radiation research - Experimental Data strongly needed to benchmark and improve existing MC codes…and for implementation in TPS! Workshop: la radiobiologia in INFN – Trento, Maggio 2016

Conclusions -Significant advances can still be achieved in charged particle therapy, provided that the uncertainties in key physical and biological aspects are reduced. -Experimental and modeling studies are needed to fill the current gaps (e.g. target fragmentation, range uncertainty, new ions). -The robust implementation of a variable RBE represents the frontier in proton therapy treatment planning. -Integration of NTCP models into planning optimization might become a key tool for patient selection. -Goal: increasing treatment effectiveness and enlarging the spectrum of patients that could benefit from proton therapy (e.g. breast cancer, pancreatic cancer). Workshop: la radiobiologia in INFN – Trento, Maggio 2016

Thank you! Workshop: la radiobiologia in INFN – Trento, Maggio 2016